Why the study?
Are preexisting morbidities independent risk factors for perioperative acute thromboembolism syndrome and death in surgery patients?
Are preexisting morbidities independent risk factors for perioperative acute thromboembolism syndrome and death in surgery patients?
Preexisting cardiac, cerebrovascular, metabolic diseases, and cancer are significant independent risk factors for perioperative acute thromboembolism and death.
Answers are grounded in this paper and cite their sources.
AF/CAD history was associated with higher perioperative MI risk and cancer with thromboembolism; hypothesis-generating for targeted prevention trials.
HYPOTHESIS: Preexisting morbidities are risk factors for perioperative arterial or venous thromboembolic events and subsequent death within 30 postoperative days. DESIGN: Prospective cohort study. SETTING: University-affiliated general hospital. PATIENTS: A total of 21,903 surgery patients treated from January 1, 1991, through December 31, 2002. MAIN OUTCOME MEASURES: Independent risk factors for perioperative arterial or venous thromboembolic events. RESULTS: History of atrial fibrillation and coronary artery disease increased the risk of myocardial infarction (odds ratio [95% confidence interval], 4.3 [2.8-6.7]). History of stroke increased the risk of stroke (2.4 [1.4-4.1]) and death (4.7 [1.3-17.3]). Diabetes mellitus increased the risk of myocardial infarction (2.1 [1.3-3.2]), and hyperuricemia increased the risk of stroke (3.5 [1.2-9.8]), and both increased the risk of death (4.3 [1.3-14.1] and 11.8 [2.2-63.5], respectively). History of myocardial infarction increased the risk of deep vein thrombosis (7.7 [1.7-34.7]). Cancer increased the risk of all thromboembolism (2.4 [1.9-3.2]). Trend analysis showed that preexisting morbidities will increase 1.5-fold and thromboembolic events will increase 3-fold during the next decade. CONCLUSION: Cardiac and cerebrovascular diseases, metabolic diseases, and cancer are becoming increasingly high-risk comorbidities for perioperative acute thromboembolism syndrome.
No takes yet. Share an insight, caveat, or question.
Mutsuhito Kikura (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: